AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Varngliz M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

SB Lifesciences

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Varngliz M 80mg/500mg Tablet

Diabetic patients using Metglin-80/500mg tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This combination therapy regulates blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood glucose monitoring. Continuous use is crucial; abrupt cessation without physician consultation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Maintain regular mealtimes and carry readily available glucose sources like juice or sweets. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects are altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential consequence. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before initiating treatment; pregnancy or breastfeeding necessitates physician consultation. Regular blood glucose monitoring and potential blood tests for complete blood count and liver function are essential.

Uses of Varngliz M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Varngliz M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Varngliz M 80mg/500mg tablets should be administered with a meal.

Common Side effects of Varngliz M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Varngliz M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Varngliz M 80mg/500mg Tablet should be administered with a meal.

How Varngliz M 80mg/500mg Tablet works:

Each Varngliz M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Varngliz M 80mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Varngliz M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical counsel.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Varngliz M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Varngliz M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Varngliz M 80mg/500mg tablets. Medical supervision, including regular kidney function tests, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Varngliz M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease may begin with a reduced dose; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is essential.

What if you forget to take Varngliz M 80mg/500mg Tablet :

Should you forget to take your Varngliz M 80mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Varngliz M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Varngliz M 80mg/500mg Tablet

Varngliz M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Varngliz M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Varngliz M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Varngliz M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is less likely in patients without kidney disease, who are not elderly, and who don't consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Varngliz M 80mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Varngliz M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Varngliz M 80mg/500mg tablets with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Varngliz M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Varngliz M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Varngliz M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Varngliz M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Varngliz M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Varngliz M 80mg/500mg Tablet is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Varngliz M 80mg/500mg tablets is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Varngliz M 80mg/500mg Tab...
43
MRP 52
17% off